Department of Biochemistry and Microbiology, University of Victoria, 3800 Finnerty Drive, Victoria BC, V8P 5C2, Canada.
Medical Research Council (MRC) Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0QH, UK.
Trends Biochem Sci. 2015 Feb;40(2):88-100. doi: 10.1016/j.tibs.2014.12.003. Epub 2015 Jan 5.
The class I phosphoinositide 3-kinases (PI3Ks) are lipid kinases that transduce a host of cellular signals and regulate a broad range of essential functions including growth, proliferation, and migration. As such, PI3Ks have pivotal roles in diseases such as cancer, diabetes, primary immune disorders, and inflammation. These enzymes are activated downstream of numerous activating stimuli including receptor tyrosine kinases, G protein-coupled receptors (GPCRs), and the Ras superfamily of small G proteins. A major challenge is to decipher how each PI3K isoform is able to successfully synergize these inputs into their intended signaling function. This article highlights recent progress in characterizing the molecular mechanisms of PI3K isoform-specific activation pathways, as well as novel roles for PI3Ks in human diseases, specifically cancer and immune diseases.
I 类磷酸肌醇 3-激酶(PI3Ks)是脂质激酶,可转导多种细胞信号,并调节包括生长、增殖和迁移在内的广泛基本功能。因此,PI3Ks 在癌症、糖尿病、原发性免疫紊乱和炎症等疾病中起着关键作用。这些酶在许多激活刺激物下游被激活,包括受体酪氨酸激酶、G 蛋白偶联受体(GPCRs)和 Ras 超家族小 G 蛋白。主要的挑战是要弄清每种 PI3K 同工型如何能够成功地将这些输入协同作用于其预期的信号功能。本文重点介绍了表征 PI3K 同工型特异性激活途径的分子机制的最新进展,以及 PI3Ks 在人类疾病(特别是癌症和免疫疾病)中的新作用。